91 related articles for article (PubMed ID: 17569840)
1. Marine biology. Florida red tide brews up drug lead for cystic fibrosis.
Potera C
Science; 2007 Jun; 316(5831):1561-2. PubMed ID: 17569840
[TBL] [Abstract][Full Text] [Related]
2. Brevenal is a natural inhibitor of brevetoxin action in sodium channel receptor binding assays.
Bourdelais AJ; Campbell S; Jacocks H; Naar J; Wright JL; Carsi J; Baden DG
Cell Mol Neurobiol; 2004 Aug; 24(4):553-63. PubMed ID: 15233378
[TBL] [Abstract][Full Text] [Related]
3. Airway responses to aerosolized brevetoxins in an animal model of asthma.
Abraham WM; Bourdelais AJ; Sabater JR; Ahmed A; Lee TA; Serebriakov I; Baden DG
Am J Respir Crit Care Med; 2005 Jan; 171(1):26-34. PubMed ID: 15447946
[TBL] [Abstract][Full Text] [Related]
4. Structure activity relationship of brevenal hydrazide derivatives.
Goodman A; McCall JR; Jacocks HM; Thompson A; Baden D; Abraham WM; Bourdelais A
Mar Drugs; 2014 Mar; 12(4):1839-58. PubMed ID: 24686558
[TBL] [Abstract][Full Text] [Related]
5. Aerosolized red-tide toxins (brevetoxins) and asthma.
Fleming LE; Kirkpatrick B; Backer LC; Bean JA; Wanner A; Reich A; Zaias J; Cheng YS; Pierce R; Naar J; Abraham WM; Baden DG
Chest; 2007 Jan; 131(1):187-94. PubMed ID: 17218574
[TBL] [Abstract][Full Text] [Related]
6. Effects of brevetoxins on murine myeloma SP2/O cells: aberrant cellular division.
Han TK; Derby M; Martin DF; Wright SD; Dao ML
Int J Toxicol; 2003; 22(2):73-80. PubMed ID: 12745987
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic modulation of salt and water in the airway epithelium in cystic fibrosis.
Knowles MR; Olivier K; Noone P; Boucher RC
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S65-9. PubMed ID: 7533608
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of gametes and embryos of the eastern oyster, Crassostrea virginica, to Karenia brevis and its toxins.
Rolton A; Soudant P; Vignier J; Pierce R; Henry M; Shumway SE; Bricelj VM; Volety AK
Toxicon; 2015 Jun; 99():6-15. PubMed ID: 25771241
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC
N Engl J Med; 1990 Apr; 322(17):1189-94. PubMed ID: 2157983
[TBL] [Abstract][Full Text] [Related]
10. A cellular target for the lipophilic toxins from Karenia brevisulcata.
Truman P
Toxicon; 2007 Aug; 50(2):251-5. PubMed ID: 17490696
[TBL] [Abstract][Full Text] [Related]
11. Amiloride for lung disease in cystic fibrosis.
Zahaykevich A
DICP; 1991 Dec; 25(12):1340-1. PubMed ID: 1815431
[No Abstract] [Full Text] [Related]
12. Brevenal, a Marine Natural Product, is Anti-Inflammatory and an Immunomodulator of Macrophage and Lung Epithelial Cells.
Keeler DM; Grandal MK; McCall JR
Mar Drugs; 2019 Mar; 17(3):. PubMed ID: 30897777
[TBL] [Abstract][Full Text] [Related]
13. Crystallization and toxicology of T34: a major toxin from Florida's red tide organism (Ptychodiscus brevis).
Baden DG; Mende TJ; Lichter W; Wellham L
Toxicon; 1981; 19(4):455-62. PubMed ID: 7199210
[No Abstract] [Full Text] [Related]
14. Artificial ladder-shaped polyethers that inhibit maitotoxin-induced Ca2+ influx in rat glioma C6 cells.
Oishi T; Konoki K; Tamate R; Torikai K; Hasegawa F; Matsumori N; Murata M
Bioorg Med Chem Lett; 2012 Jun; 22(11):3619-22. PubMed ID: 22560474
[TBL] [Abstract][Full Text] [Related]
15. Brevetoxicosis: red tides and marine mammal mortalities.
Flewelling LJ; Naar JP; Abbott JP; Baden DG; Barros NB; Bossart GD; Bottein MY; Hammond DG; Haubold EM; Heil CA; Henry MS; Jacocks HM; Leighfield TA; Pierce RH; Pitchford TD; Rommel SA; Scott PS; Steidinger KA; Truby EW; Van Dolah FM; Landsberg JH
Nature; 2005 Jun; 435(7043):755-6. PubMed ID: 15944690
[TBL] [Abstract][Full Text] [Related]
16. Brevisulcatic acids, marine ladder-frame polyethers from the red tide dinoflagellate Karenia brevisulcata in New Zealand.
Suzuki R; Irie R; Harntaweesup Y; Tachibana K; Holland PT; Harwood DT; Shi F; Beuzenberg V; Itoh Y; Pascal S; Edwards PJ; Satake M
Org Lett; 2014 Nov; 16(22):5850-3. PubMed ID: 25356530
[TBL] [Abstract][Full Text] [Related]
17. Trends in therapy of abnormal airway epithelial ion and liquid transport.
Noone PG; Knowles MR
Monaldi Arch Chest Dis; 1993; 48(2):140-3. PubMed ID: 7686073
[TBL] [Abstract][Full Text] [Related]
18. Marine brevetoxin induces IgE-independent mast cell activation.
Hilderbrand SC; Murrell RN; Gibson JE; Brown JM
Arch Toxicol; 2011 Feb; 85(2):135-41. PubMed ID: 20549194
[TBL] [Abstract][Full Text] [Related]
19. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
App EM; King M; Helfesrieder R; Köhler D; Matthys H
Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093
[TBL] [Abstract][Full Text] [Related]
20. Fate and distribution of brevetoxin (PbTx) following lysis of Karenia brevis by algicidal bacteria, including analysis of open A-ring derivatives.
Roth PB; Twiner MJ; Wang Z; Bottein Dechraoui MY; Doucette GJ
Toxicon; 2007 Dec; 50(8):1175-91. PubMed ID: 17905402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
